These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 21793172

  • 21. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [Abstract] [Full Text] [Related]

  • 22. Percutaneous coronary intervention for small vessel coronary artery disease.
    Biondi-Zoccai G, Moretti C, Abbate A, Sheiban I.
    Cardiovasc Revasc Med; 2010 Oct; 11(3):189-98. PubMed ID: 20599174
    [Abstract] [Full Text] [Related]

  • 23. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):15-21. PubMed ID: 19089930
    [Abstract] [Full Text] [Related]

  • 24. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.
    Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Pichard AD, Waksman R.
    Arch Cardiovasc Dis; 2009 Feb 01; 102(2):143-51. PubMed ID: 19303582
    [Abstract] [Full Text] [Related]

  • 25. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, Neunteufl T, Badr-Eslam R, Winkler S, Nyolczas N, Posa A, Leisch F, Karnik R, Siostrzonek P, Harb S, Heigert M, Zenker G, Benzer W, Bonner G, Kaider A, Glogar D, AUTAX Investigators.
    JACC Cardiovasc Interv; 2009 Aug 01; 2(8):718-27. PubMed ID: 19695539
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW, SYNTAX Trial Investigators.
    Circulation; 2014 Sep 30; 130(14):1146-57. PubMed ID: 25085960
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
    Lee MS, Yang T, Fearon WF, Ho M, Tarantini G, Xhaxho J, Gerosa G, Weston M, Ehdaie A, Rabbani L, Kirtane AJ.
    Am J Cardiol; 2010 Oct 15; 106(8):1086-9. PubMed ID: 20920643
    [Abstract] [Full Text] [Related]

  • 28. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.
    Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW.
    J Am Coll Cardiol; 2011 Feb 01; 57(5):538-45. PubMed ID: 21272743
    [Abstract] [Full Text] [Related]

  • 29. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
    Conrotto F, Scacciatella P, D'Ascenzo F, Chieffo A, Latib A, Park SJ, Kim YH, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Chakravarty T, Mehran R, Naber C, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice MC, Erglis A, Tamburino C, Alfieri O, D'Amico M, Marra S, Serruys PW, Colombo A, Meliga E.
    Am J Cardiol; 2014 Jun 15; 113(12):2007-12. PubMed ID: 24793677
    [Abstract] [Full Text] [Related]

  • 30. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
    Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F.
    JACC Cardiovasc Interv; 2011 Mar 15; 4(3):327-35. PubMed ID: 21435612
    [Abstract] [Full Text] [Related]

  • 31. Drug-eluting stent for unprotected left main coronary artery disease: early and mid-term outcomes.
    Tassanawiwat W, Mahavanakul W, Thanakitcharu P, Komolsart P, Chansod S, Sookananchai B, Wongvipaporn C, Kiatchoosakun S, Cheiniwat S, Tresukosol D.
    J Med Assoc Thai; 2010 Sep 15; 93(9):1030-6. PubMed ID: 20873074
    [Abstract] [Full Text] [Related]

  • 32. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
    Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Smith H, Edmunds J, Varanasi J, Simonton CA, STENT (Strategic Transcatheter Evaluation of New Therapies) Group.
    JACC Cardiovasc Interv; 2008 Aug 15; 1(4):405-14. PubMed ID: 19463338
    [Abstract] [Full Text] [Related]

  • 33. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C.
    JACC Cardiovasc Interv; 2011 Mar 15; 4(3):287-97. PubMed ID: 21435606
    [Abstract] [Full Text] [Related]

  • 34. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Vassilev D, Fraccaro C, Roncon L, Faggian G.
    Cardiovasc Revasc Med; 2014 Mar 15; 15(2):76-9. PubMed ID: 24560299
    [Abstract] [Full Text] [Related]

  • 35. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J, Udayachalerm W, Srimahachota S, Buddhari W, Chaipromprasit J, Songmuang SB, Suithichaiyakul T.
    J Med Assoc Thai; 2009 Jun 15; 92(6):755-60. PubMed ID: 19530580
    [Abstract] [Full Text] [Related]

  • 36. Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
    De Caterina AR, Cuculi F, Banning AP.
    EuroIntervention; 2013 Mar 15; 8(11):1326-34. PubMed ID: 23538159
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C, EXECUTIVE Trial Investigators.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1012-22. PubMed ID: 24055444
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.